Home / TTC28 Knockout Cell Lines

TTC28 Knockout Cell Lines

Gene: TTC28

Official Full Name: tetratricopeptide repeat domain 28provided by HGNC

Gene Summary: Enables kinase binding activity. Involved in regulation of mitotic cell cycle. Located in midbody. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO29413 TTC28 Knockout cell line (HeLa) Human TTC28 1:3~1:6 Negative Online Inquiry
KO29414 TTC28 Knockout cell line (HEK293) Human TTC28 1:3~1:6 Negative Online Inquiry
KO29415 TTC28 Knockout cell line (A549) Human TTC28 1:3~1:4 Negative Online Inquiry

Background

TTC28 Gene Knockout Cell Lines are genetically engineered cellular models designed to facilitate the study of the TTC28 gene's function and its involvement in cellular processes. Knockout cell lines are derived using CRISPR/Cas9 technology, enabling precise alterations within the host genome to eliminate the expression of targeted genes. These versatile models provide researchers with the ability to explore the biological impacts of gene inactivation in various contexts, making them essential tools for studying gene functionality and disease mechanisms.

The primary function of TTC28 Gene Knockout Cell Lines is to investigate the cellular consequences of the absence of the TTC28 protein, which has been implicated in cellular signaling pathways, protein interaction networks, and cellular stress response mechanisms. By utilizing these knockout models, researchers can examine changes in cell proliferation, differentiation, and apoptosis under controlled experimental conditions. The mechanistic insights gleaned from these studies can significantly broaden our understanding of the physiological and pathological roles of the TTC28 gene.

The scientific importance of TTC28 Gene Knockout Cell Lines is underscored by their utility in both basic and applied research. In clinical settings, these cell lines can aid in elucidating the role of TTC28 in diseases such as cancer, neurodegenerative disorders, and metabolic syndromes. Moreover, they represent valuable tools for drug discovery and development, enabling the identification of potential therapeutic targets and biomarkers.

One of the key advantages of our TTC28 Gene Knockout Cell Lines compared to other models is the precision of CRISPR technology, which minimizes off-target effects and ensures the reliability of experimental outcomes. Additionally, our cell lines are fully characterized and validated, providing researchers with confidence in their stability and performance in various assays.

By leveraging our TTC28 Gene Knockout Cell Lines, researchers and clinicians can obtain high-quality, reproducible results that advance their understanding of gene function in health and disease. Our commitment to providing cutting-edge biological products is backed by years of expertise in genetic engineering and cell biology, ensuring that you receive products that meet the highest standards of scientific integrity and reliability.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.